The parameters included all antigen-specific CD4+ T cell, CD8+ T cell, and antibody measurements (Figures 1, 2, 3, 4, S1, S2, S3, and S4), plus general immune cell type measurements, plasma cytokines, age, comorbidities, and COVID-19 clinical disease severity. The gene discussed is CD8A; the disease is COVID-19.